Centene Corp (CNC)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $35.28B
Last updated: Nov 17, 2026 at 11:05 AM ET
Centene Corp (CNC) Financials: Revenue, Profit and Cash Flow
Centene reported revenue of $194.78B for the fiscal year ended Dec 31, 2025, up 19.4% from the year before. That year, net income was -$6.68B with a net margin of -3.4%, operating cash flow was $5.09B and free cash flow was $4.32B. The quarter ended Sep 30, 2026 had revenue of $50.65B and net income of -$65.00M.
Revenue and Margins
The operating margin was -3.9% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $40.61B, a compound annual rate of 19.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $194.78B | +19.4% | 98.6% | -3.9% | -3.4% |
| Dec 2024 | $163.07B | +5.9% | 98.3% | 1.9% | 2.0% |
| Dec 2023 | $154.00B | +6.5% | 97.7% | 1.9% | 1.8% |
| Dec 2022 | $144.55B | +14.7% | 95.1% | 0.9% | 0.8% |
| Dec 2021 | $125.98B | +13.4% | 17.8% | 1.4% | 1.1% |
| Dec 2020 | $111.11B | +48.9% | 19.4% | 2.8% | 1.6% |
| Dec 2019 | $74.64B | +24.2% | 96.7% | 2.4% | 1.8% |
| Dec 2018 | $60.12B | +24.3% | 19.4% | 2.4% | 1.5% |
| Dec 2017 | $48.38B | +19.1% | 17.9% | 2.5% | 1.7% |
| Dec 2016 | $40.61B | N/A | 20.0% | 3.1% | 1.4% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B |
| Cost of revenue | $2.67B | $2.73B | $3.56B | $7.03B | $103.50B | $89.57B | $2.46B | $48.44B | $39.70B | $32.50B |
| Gross profit | $192.11B | $160.34B | $150.44B | $137.51B | $22.49B | $21.55B | $72.17B | $11.67B | $8.68B | $8.11B |
| Operating income | -$7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B |
| Net income | -$6.68B | $3.29B | $2.70B | $1.20B | $1.34B | $1.79B | $1.31B | $894.00M | $808.00M | $561.00M |
| EBITDA | -$6.35B | $4.42B | $4.22B | $2.78B | $2.99B | $4.34B | $2.42B | $1.95B | $1.56B | $1.54B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.65B | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B |
| Gross profit | $49.97B | $52.85B | $49.24B | $49.05B | $49.04B | $48.10B | $45.92B | $40.12B | $41.33B | $39.16B | $39.74B | $38.50B |
| Operating income | -$307.00M | $1.20B | $1.86B | -$1.75B | -$6.95B | -$458.00M | $1.53B | $175.00M | $665.00M | $1.23B | $1.11B | -$194.00M |
| Net income | -$65.00M | $1.09B | $1.54B | -$1.10B | -$6.63B | -$259.00M | $1.31B | $280.00M | $710.00M | $1.15B | $1.16B | $39.00M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $17.40B by $487.00M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B |
| Current assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B |
| Cash and equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B |
| Total liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B |
| Short-term debt | $50.00M | $110.00M | $119.00M | $82.00M | $267.00M | $97.00M | $88.00M | $38.00M | $4.00M | $4.00M |
| Long-term debt | $17.35B | $18.42B | $17.71B | $17.94B | $18.57B | $16.68B | $13.64B | $6.65B | $4.70B | $4.65B |
| Shareholder equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $79.28B | $83.01B | $81.17B | $77.66B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | $84.64B |
| Total liabilities | $56.97B | $60.35B | $59.65B | $57.60B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | $58.69B |
| Cash and equivalents | $20.70B | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B |
| Shareholder equity | $22.21B | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | $25.84B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 84.9% of operating cash flow. Dividends and share repurchases together came to 11.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.09B | $154.00M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B |
| Capital expenditures | $767.00M | $644.00M | $799.00M | $1.00B | $910.00M | $869.00M | $730.00M | $675.00M | $422.00M | $306.00M |
| Free cash flow | $4.32B | -$490.00M | $7.25B | $5.26B | $3.29B | $4.63B | $753.00M | $559.00M | $1.07B | $1.54B |
| Dividends paid | $19.00M | $0 | $88.00M | $0 | $0 | N/A | N/A | $6.08B | $66.00M | $14.00M |
| Share repurchases | $475.00M | $3.12B | $1.63B | $3.10B | $297.00M | $626.00M | $75.00M | $71.00M | $65.00M | $63.00M |
| Investing cash flow | $472.00M | -$1.05B | -$1.19B | -$2.92B | -$3.30B | -$6.96B | -$1.53B | -$4.58B | -$1.25B | -$2.47B |
| Financing cash flow | -$1.62B | -$2.41B | -$1.66B | -$4.20B | $1.36B | $260.00M | $6.83B | $4.61B | -$82.00M | $2.72B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.67B | $3.59B | $4.37B | $437.00M | $1.36B | $1.78B | $1.51B | -$587.00M | -$978.00M | $2.17B | -$456.00M | $217.00M |
| Capital expenditures | $194.00M | $174.00M | $200.00M | $213.00M | $211.00M | $208.00M | $135.00M | $154.00M | $153.00M | $186.00M | $151.00M | $223.00M |
| Free cash flow | -$3.86B | $3.42B | $4.17B | $224.00M | $1.15B | $1.58B | $1.38B | -$741.00M | -$1.13B | $1.99B | -$607.00M | -$6.00M |
Frequently Asked Questions About CNC
What is Centene's annual revenue?
Centene reported revenue of $194.78B for the fiscal year ended Dec 31, 2025.
How fast is Centene's revenue growing?
Revenue was up 19.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.5%.
Is Centene profitable?
No. Centene reported net income of -$6.68B for the fiscal year ended Dec 31, 2025, with a net margin of -3.4%.
How much free cash flow does CNC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $5.09B minus capital expenditures of $767.00M produced free cash flow of $4.32B.
How much debt does Centene have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $17.35B, short-term debt of $50.00M and cash and equivalents of $17.89B.
CNC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts